Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
Melamed E, Zoldan J, Galili-Mosberg R, Ziv I, Djaldetti R.
Melamed E, et al.
J Neural Transm Suppl. 1999;56:173-83. doi: 10.1007/978-3-7091-6360-3_11.
J Neural Transm Suppl. 1999.
PMID: 10370911
Review.
Oral and s.c. administration of novel, extremely soluble prodrugs of levodopa, e.g., levodopa ethylester, may offer a new approach to overcome difficulties in levodopa absorption. ...Levodopa, administered orally, usually combined with peripheral dopa decarboxylase inhibit …
Oral and s.c. administration of novel, extremely soluble prodrugs of levodopa, e.g., levodopa ethylester, may offer a new approach to …